These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 34108552

  • 1. Prognostic significance of bone marrow and spleen 18F-FDG uptake in patients with colorectal cancer.
    Lee JH, Lee HS, Kim S, Park EJ, Baik SH, Jeon TJ, Lee KY, Ryu YH, Kang J.
    Sci Rep; 2021 Jun 09; 11(1):12137. PubMed ID: 34108552
    [Abstract] [Full Text] [Related]

  • 2. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Lee JW, Na JO, Kang DY, Lee SY, Lee SM.
    Clin Lung Cancer; 2017 Mar 09; 18(2):198-206. PubMed ID: 27495385
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia.
    Pijl JP, Kwee TC, Slart RHJA, Yakar D, Wouthuyzen-Bakker M, Glaudemans AWJM.
    Eur J Nucl Med Mol Imaging; 2021 May 09; 48(5):1467-1477. PubMed ID: 33106925
    [Abstract] [Full Text] [Related]

  • 6. Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection.
    Lee JW, Lee MS, Chung IK, Son MW, Cho YS, Lee SM.
    World J Gastroenterol; 2017 Apr 07; 23(13):2385-2395. PubMed ID: 28428718
    [Abstract] [Full Text] [Related]

  • 7. The prognostic value of bone marrow retention index and bone marrow-to-liver ratio of baseline 18F-FDG PET/CT in diffuse large B-cell lymphoma.
    El-Azony A, Basha MAA, Almalki YE, Abdelmaksoud B, Hefzi N, Alnagar AA, Mahdey S, Ali IM, Nasr I, Abdalla AAEM, Yousef HY, Zaitoun MMA, Elsayed SB, Nada MG, Amin MI, Hassan RM, Ali SA, Dawoud TM, Aly SA, Algazzar YH, Abdelhamed H.
    Eur Radiol; 2024 Apr 07; 34(4):2500-2511. PubMed ID: 37812294
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of diffuse splenic FDG uptake on PET/CT in patients with gastric cancer.
    Yoon HJ, Kim BS, Moon CM, Yoo J, Lee KE, Kim Y.
    PLoS One; 2018 Apr 07; 13(4):e0196110. PubMed ID: 29698422
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of diffuse increased fluorine-18-fluorodeoxyglucose (18F-FDG) uptake within the reticuloendothelial system in lymphoma patients.
    Zhao Z, Zhou Y, Yao X, Ge S, Sang S, Yang Y, Zhang B, Deng S.
    Quant Imaging Med Surg; 2024 Sep 01; 14(9):6374-6385. PubMed ID: 39281118
    [Abstract] [Full Text] [Related]

  • 10. Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study.
    Lee JW, Ahn H, Yoo ID, Hong SP, Baek MJ, Kang DH, Lee SM.
    Cancer Imaging; 2024 Apr 16; 24(1):53. PubMed ID: 38627864
    [Abstract] [Full Text] [Related]

  • 11. Fluorine-18-fluorodeoxyglucose uptake of bone marrow on PET/CT can predict prognosis in patients with colorectal cancer after curative surgical resection.
    Lee JW, Baek MJ, Ahn TS, Lee SM.
    Eur J Gastroenterol Hepatol; 2018 Feb 16; 30(2):187-194. PubMed ID: 29120905
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elevated tumor-to-liver uptake ratio (TLR) from 18F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection.
    Huang J, Huang L, Zhou J, Duan Y, Zhang Z, Wang X, Huang P, Tan S, Hu P, Wang J, Huang M.
    Eur J Nucl Med Mol Imaging; 2017 Nov 16; 44(12):1958-1968. PubMed ID: 28812134
    [Abstract] [Full Text] [Related]

  • 15. PET-CT for Evaluation of Spleen and Liver 18F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma.
    Rao L, Wang X, Zong Z, Chen Z, Shi X, Yi C, Zhang X, Yang Z.
    Medicine (Baltimore); 2016 May 16; 95(20):e3750. PubMed ID: 27196500
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tumor metabolic and secondary lymphoid organ metabolic markers on 18F-fludeoxyglucose positron emission tomography predict prognosis of immune checkpoint inhibitors in advanced lung cancer.
    Jin P, Bai M, Liu J, Yu J, Meng X.
    Front Immunol; 2022 May 16; 13():1004351. PubMed ID: 36341372
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy.
    Seban RD, Assié JB, Giroux-Leprieur E, Massiani MA, Bonardel G, Chouaid C, Deleval N, Richard C, Mezquita L, Girard N, Champion L.
    Lung Cancer; 2021 Sep 16; 159():45-55. PubMed ID: 34311344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.